Cardio-oncological management of patients

Daniela M. Cardinale, Ana Barac, Adam Torbicki, Bijoy K. Khandheria, Daniel Lenihan, Giorgio Minotti

Research output: Contribution to journalReview articlepeer-review


Session III of the Second International Colloquium on Cardio-Oncology focused on the diagnosis, management, and prevention of cardiovascular toxicity of cancer drugs. With a large menu of biomarkers and imaging modalities available to the cardio oncologist, there continues to be no consensus regarding the best use of each modality alone and in combination and whether we can actually prevent early and late cardiotoxicity using these tests to guide a preventive strategy. It has become increasingly clear that early diagnosis and intervention leads to less late cardiotoxicity and fewer cardiac-related events. This can be accomplished by taking a thorough history and performing a goal directed physical examination coupled with use of biomarkers and imaging studies. This session attempted to provide rationale for a current and integrated approach to these issues.

Original languageEnglish
Pages (from-to)408-413
Number of pages6
JournalSeminars in Oncology
Issue number6
Publication statusPublished - Dec 2019


  • Cancer drugs
  • Cardiovascular toxicity
  • Imaging
  • Prevention
  • Risk
  • Treatment

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Cardio-oncological management of patients'. Together they form a unique fingerprint.

Cite this